- Home
- SNT vs XBIT Comparison
SNT vs XBIT Comparison
Compare SNT & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- XBIT
- Stock Information
- Founded
- SNT 1965
- XBIT 2005
- Country
- SNT Canada
- XBIT United States
- Employees
- SNT N/A
- XBIT N/A
- Industry
- SNT Telecommunications Equipment
- XBIT Pharmaceuticals and Biotechnology
- Sector
- SNT Telecommunications
- XBIT Health Care
- Exchange
- SNT Nasdaq
- XBIT Nasdaq
- Market Cap
- SNT 95.2M
- XBIT 86.3M
- IPO Year
- SNT 1993
- XBIT 2015
- Fundamental
- Price
- SNT $4.29
- XBIT $3.15
- Analyst Decision
- SNT
- XBIT
- Analyst Count
- SNT 0
- XBIT 0
- Target Price
- SNT N/A
- XBIT N/A
- AVG Volume (30 Days)
- SNT 40.8K
- XBIT 39.7K
- Earning Date
- SNT 08-25-2025
- XBIT 08-13-2025
- Dividend Yield
- SNT N/A
- XBIT N/A
- EPS Growth
- SNT N/A
- XBIT N/A
- EPS
- SNT 0.18
- XBIT N/A
- Revenue
- SNT $36,690,000.00
- XBIT N/A
- Revenue This Year
- SNT N/A
- XBIT N/A
- Revenue Next Year
- SNT N/A
- XBIT N/A
- P/E Ratio
- SNT $23.83
- XBIT N/A
- Revenue Growth
- SNT 8.36
- XBIT N/A
- 52 Week Low
- SNT $1.40
- XBIT $2.50
- 52 Week High
- SNT $5.04
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- SNT 48.62
- XBIT 61.04
- Support Level
- SNT $3.91
- XBIT $2.82
- Resistance Level
- SNT $4.40
- XBIT $3.33
- Average True Range (ATR)
- SNT 0.25
- XBIT 0.13
- MACD
- SNT -0.01
- XBIT 0.03
- Stochastic Oscillator
- SNT 52.05
- XBIT 66.67
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.